As the biotech industry continues to rapidly evolve, staying ahead of the curve requires agile decision-making and robust commercialization strategies.
In this webinar, the expert speakers will explore the key trends and challenges shaping today’s biotech landscape and provide actionable insights for navigating deals, evaluating assets and preparing for successful product launches.
In a time of shifting macroeconomic conditions, with fluctuating capital markets and rising interest rates, deal structures in biotech are undergoing significant changes. The expert speakers will thus examine how these factors influence deal-making strategies, highlighting emerging global hotspots in areas such as oncology and rare diseases.
They will also explore how market trends and evolving patient needs are driving asset valuation and risk mitigation strategies. From early-stage development to late-stage pipeline decisions, they will highlight critical go/no-go decisions, assessing whether an independent path or partnership offers the most value and the potential for long-term success.
In this webinar, attendees will gain insights into the latest market access trends, such as the increasing emphasis on personalized medicine and patient-centric solutions. The expert speakers will offer practical guidance on building the necessary infrastructure for market entry, including regulatory filings, reimbursement strategies and supply chain coordination.
This webinar is designed for biotech executives and investors seeking to navigate strategic partnerships and acquisitions, create compelling value propositions and ensure launch readiness.
Register for webinar today to gain insights into navigating deal-making, optimizing go/no-go decisions and building commercialization strategies that drive successful product launches in today’s biotech market.
Speakers
Jessica Cortez, Principal, Avalere Health
Jessica Cortez has extensive experience partnering with life sciences organizations to drive strategic initiatives focused on healthcare transformation. At Avalere Health, Jessica leads the annual dissection of the Medicare Physician Fee Schedule (MPFS), where she specializes in coverage, coding, regulatory, and economics—always with a strong focus on physician net cost recovery and enhancing the patient experience.
In previous roles, she played a pivotal part in transforming healthcare systems. At US Bioservices, she co-led the reimbursement department and oversaw the successful lift and shift to Inovalon’s ScriptMed pharmacy operating system, streamlining operations across a national network of specialty pharmacies. Her efforts significantly enhanced both patient experiences and provider satisfaction. At BMS, she supported healthcare providers in gaining and maintaining access to the company’s products, launching five major drugs, and breaking down financial barriers to ensure patients received essential medications.
Message Presenter
Mike deMilt, Principal, Market Access, Avalere Health
Mike deMilt helps life sciences clients navigate market dynamics, optimize pipelines and develop access and commercialization strategies. Before joining Avalere Health, he served as Vice President at Destum Partners, where he led strategic engagements and advisory mandates, supporting transactions for clients across the US, Europe and global markets.
With over a decade of experience advising companies across all phases of development, Mike has shaped corporate strategy through market and financial analytics. Earlier in his career, he worked at Tetracore, where he contributed to the development of diagnostic technologies for infectious diseases and bioterrorism threats.
Message Presenter
Maria Katsarou, Senior Consultant, Business Strategy, Avalere Health
Maria Katsarou specializes in New Product Planning, Pipeline & Portfolio Strategy, and Corporate Development for biotech clients. She brings deep therapeutic expertise in oncology, immunology, and neuroscience, with a strong focus on advanced therapies and complex service models. Maria holds a master’s degree in Cell and Gene Therapy from University College London and is passionate about supporting strategic decision-making in the ATMP space. She works closely with emerging biotechs to shape asset strategy, evaluate partnerships, and enable early commercialization and successful market entry.
Message Presenter
Bryan Jack, Managing Director, Client Partnerships, Avalere Health
Bryan Jack leads the life sciences account management and business development functions at Avalere Health. Over his 7+ years at the company, he has worked directly with hundreds of clients – big and small, emerging and established – to design and deliver strategic, impactful, and data-driven advisory services. Prior to joining Avalere Health, Bryan worked at two other top-tier consultancies focusing on Medicare, Medicaid, and commercial insurance strategy and operations. He started his career as a legislative staffer in the US House of Representatives.
Message PresenterWho Should Attend?
This webinar is designed for biotech executives and investors (venture capital and private equity) in the following roles and functions:
- C-Suite/Executive
- Clinical development/therapeutic areas
- Commercial/market access/managed markets
- Corporate strategy/business development
- Development programs/finance
- Health economics and outcomes research
- Medical affairs
What You Will Learn
Attendees will learn about:
- Observations from the deal-making environment and trends across the financial landscape and sell-side implications for biotech
- Factors impacting go/no-go decisions, including tactics to minimize risk and maximize value potential, topics frequently challenged during due diligence and deployable strategies leading up to key inflection points
- The roadmap to transitioning into an effective, integrated organization driving market access and commercial success and ensuring access to therapies for clinically appropriate patients
Xtalks Partner
Avalere Health
Avalere Health is guided by a single mission to make EVERY PATIENT POSSIBLE. Its Advisory, Medical, and Marketing capabilities move as one, ensuring every patient is identified, supported, treated, and cared for. Equally.
Avalere Health is a global strategic partner, perfectly formed to solve the biggest challenges in health—at pace and at scale. The organization is united across the product lifecycle, uniquely positioned to understand every angle of life, health, and the human condition. Partnering with its clients, its experts are building a world where healthcare is not a barrier. And no patient is left behind. Visit www.avalerehealth.com and follow Avalere Health on LinkedIn.
You Must Login To Register for this Free Webinar
Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.
Create Account